A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience


Cekdemir D., Guvenc S., Ozdemirkiran F., Eser A., Topts T., Ozkocaman V., et al.

TURKISH JOURNAL OF HEMATOLOGY, cilt.36, ss.230-237, 2019 (SCI İndekslerine Giren Dergi)

Özet

Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP).